Thymosin‐β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma

Retinoids are an important component of neuroblastoma therapy at the stage of minimal residual disease, yet 40–50% of patients treated with 13‐cis‐retinoic acid (13‐cis‐RA) still relapse, indicating the need for more effective retinoid therapy. Vorinostat, or Suberoylanilide hydroxamic acid (SAHA),...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Oncol
Main Authors: Cheung, Belamy B., Tan, Owen, Koach, Jessica, Liu, Bing, Shum, Michael S.Y., Carter, Daniel R., Sutton, Selina, Po'uha, Sela T., Chesler, Louis, Haber, Michelle, Norris, Murray D., Kavallaris, Maria, Liu, Tao, O'Neill, Geraldine M., Marshall, Glenn M.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2015
Fag:
Research Papers
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528804/
https://ncbi.nlm.nih.gov/pubmed/25963741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.04.005
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker